Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Peregrine Pharmaceuticals Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Peregrine Pharmaceuticals Inc since year 2005.
Table 2 shows the detailed insider transactions of Peregrine Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is PPHM. The reporting company's CIK number is 704562.
The total value of stock buying since 2005 is $1,257,603.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $27,000.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-10-27||Bamforth Mark R||Buy||50,000||4.49||224,650|
|2012-03-14||Swartz Eric S||Buy||16,000||.62||9,936|
|2010-11-08||Swartz Eric S (Director)||Buy||10,000||1.59||15,900|
|2010-09-24||Lytle Paul J (Chief Financial Officer)||Buy||6,684||1.34||8,956|
|2010-09-23||Lytle Paul J (Chief Financial Officer)||Buy||5,000||1.33||6,650|
|2010-09-23||King Steven W (President & CEO)||Buy||5,000||1.33||6,650|
|2010-02-18||Swartz Eric S (Director)||Buy||4,300||3.29||14,125|
|2010-02-17||Swartz Eric S (Director)||Buy||17,700||3.25||57,613|
|2010-02-05||Swartz Eric S (Director)||Buy||18,000||3.05||54,954|
|2010-01-15||Swartz Eric S (Director)||Buy||20,000||3.21||64,100|
|2010-01-08||Swartz Eric S (Director)||Buy||20,000||3.12||62,360|
|2010-01-07||Swartz Eric S (Director)||Buy||20,000||2.93||58,560|
|2008-01-14||Swartz Eric S (Director)||Buy||35,000||.39||13,650|
|2007-08-31||Swartz Eric S (Director)||Buy||70,000||.71||50,200|
|2007-08-31||King Steven W (President & CEO)||Buy||4,900||.73||3,591|
|2007-08-31||Johnson Carlton M (Director)||Buy||20,162||.71||14,315|
|2007-08-30||Swartz Eric S (Director)||Buy||5,300||.67||3,556|
|2007-08-30||Johnson Carlton M (Director)||Buy||18,131||.67||12,075|
|2007-08-29||Swartz Eric S (Director)||Buy||20,419||.67||13,599|
|2007-08-28||Swartz Eric S (Director)||Buy||14,268||.66||9,416|
|2007-08-27||Swartz Eric S (Director)||Buy||16,400||.66||10,791|
|2007-08-24||King F David (V.P., Business Development)||Buy||20,000||.64||12,840|
|2007-08-21||King F David (V.P., Business Development)||Buy||16,685||.60||9,944|
|2007-08-20||Lytle Paul J (Chief Financial Officer)||Buy||16,685||.59||9,810|
|2007-08-20||King Steven W (President & CEO)||Buy||16,685||.59||9,810|
|2007-06-11||Lytle Paul J (Chief Financial Officer)||Option Ex||30,000||.60||18,000|
|2007-06-11||King Steven W (President & CEO)||Option Ex||15,000||.60||9,000|
|2006-12-22||Waltz Thomas A (Director)||Buy||2,500||1.20||2,997|
|2006-06-12||Swartz Eric S (Director)||Buy||13,000||1.87||24,323|
|2006-06-09||Swartz Eric S (Director)||Buy||28,000||1.75||48,860|
|2006-03-08||Swartz Eric S (Director)||Buy||10,000||1.24||12,400|
|2006-03-07||Swartz Eric S (Director)||Buy||20,000||1.26||25,200|
|2006-01-27||Swartz Eric S (Director)||Buy||10,000||1.15||11,500|
|2006-01-26||Swartz Eric S (Director)||Buy||10,000||1.12||11,200|
|2006-01-05||Swartz Eric S (Director)||Buy||12,000||.91||10,920|
|2005-08-12||Swartz Eric S (Director)||Buy||7,200||1.18||8,496|
|2005-07-28||Swartz Eric S (Director)||Buy||13,800||1.18||16,284|
|2005-07-20||Swartz Eric S (Director)||Buy||43,500||1.14||49,763|
|2005-07-13||Swartz Eric S (Director)||Buy||48,000||1.04||49,920|
|2005-07-08||Swartz Eric S (Director)||Buy||50,000||1.02||51,249|
|2005-07-01||Swartz Eric S (Director)||Buy||50,000||.98||48,950|
|2005-06-06||Swartz Eric S (Director)||Buy||22,500||1.12||25,200|
|2005-05-24||Swartz Eric S (Director)||Buy||44,000||1.11||48,840|
Insider trading activities including stock purchases, stock sales, and option exercises of PPHM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Peregrine Pharmaceuticals Inc (symbol PPHM, CIK number 704562) see the Securities and Exchange Commission (SEC) website.